Treatment of multiple sclerosis with rituximab: A multicentric Italian–Swiss experience:
2019
Background:Rituximab, an anti-CD20 monoclonal antibody leading to B lymphocyte depletion, is increasingly used as an off-label treatment option for multiple sclerosis (MS).Objective:To investigate ...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
17
References
16
Citations
NaN
KQI